Christine Lindenboom | Senior Vice President-Investor Relations and Corporate Communications |
Yvonne Greenstreet | Chief Executive Officer |
Tolga Tanguler | Chief Commercial Officer |
Akshay Vaishnaw | President |
Jeff Poulton | Chief Financial Officer |
Paul Matteis | Stifel |
David Lebowitz | Citi |
Salveen Richter | Goldman Sachs |
Ritu Baral | Cowen |
Tazeen Ahmad | Bank of America |
Joseph Stringer | Needham |
Maury Raycroft | Jefferies |
Luca Issi | RBC Capital |
Gary Nachman | BMO |
Anupam Rama | J.P. Morgan |
Gena Wang | Barclays |
Eliana Merle | UBS |
Myles Minter | William Blair |
Olivia Brayer | Cantor |
Hello, thank you for standing by. And welcome to the Alnylam Pharmaceuticals Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference may be recorded.